BBK Holdings

BBK Holdings was the parent company of BBK Worldwide, a healthcare-focused services business supporting biotechnology, pharmaceutical, and medical device companies with patient recruitment, clinical trial experience, and R&D marketing services. The business combined patient-centric service delivery with proprietary technology to support clinical trial enrollment, retention, and engagement rather than developing its own therapeutics. In January 2022, Publicis Health acquired BBK Worldwide and BBK Holdings as part of an expansion of its clinical trial expertise and patient engagement capabilities. The broader holding structure also included affiliated businesses such as 320Agency, TCN Technologies, and RSG Engagement Solution Center. BBK should be categorized as a healthcare services and technology company rather than a drug developer.